Brief: Gimv Exits Biolam To Its Management Backed By Investors
Dec 9 (Reuters) - Gimv NV GIMV.BR :
* EXITS BIOLAM TO ITS MANAGEMENT BACKED BY INVESTORS AFTER A
FAST
AND SUCCESSFUL GROWTH TRAJECTORY INTO A LEADING FRENCH GROUP OF
CLINICAL TESTING LABS
* TRANSACTION HAS NO SIGNIFICANT IMPACT ON THE NET ASSET
VALUE OF
GIMV AS OF 30 SEPTEMBER 2022
* NO FURTHER FINANCIAL DETAILS WILL BE DISCLOSED
Source text for Eikon: ID:nNDLWx1ZC
Further company coverage: GIMV.BR
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))